Cancer vaccine prevents deadly melanoma from returning or spreading in landmark trial
An experimental skin cancer vaccine significantly reduced the risk of melanoma returning or spreading in a late-stage clinical trial from Merck and Moderna. The results mark the first positive Phase…






